BioNTech CEO says COVID-19 vaccine expected to be up to 75 per cent effective against variant first detected in India

BioNTech CEO Ugur Sahin said Thursday that the COVID-19 vaccine developed with Pfizer should be roughly as effective against the new variant first detected in India, with it expected to be 70 to 75 per cent effective at protecting against infections.